Travis Taylor

Dr. Travis Taylor

Department of Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH, USA
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Cell Host & Microbe
Verified
Journal Article
Closed access
KLKirk J. Lubick
Kirk J. Lubick
SRShelly J. Robertson
Shelly J. Robertson
KMKristin L. McNally
Kristin L. McNally
BFBrett A. Freedman
Brett A. Freedman
Angela L. RasmussenAngela L. Rasmussen
Angela L. Rasmussen
Sonja BestSonja Best
Sonja Best

1 September 2011 in Cell Host & Microbe
Verified
Journal Article
Closed access
Travis TaylorTravis Taylor
Travis Taylor
KLKirk J. Lubick
Kirk J. Lubick
SRShelly J. Robertson
Shelly J. Robertson
JBJames P. Broughton
James P. Broughton
MBMarshall E. Bloom
Marshall E. Bloom
Sonja BestSonja Best
Sonja Best

15 March 2005 in Journal of Virology
Verified
Journal Article
Open access
PDF file
Travis TaylorTravis Taylor
Travis Taylor
WBWade A. Bresnahan
Wade A. Bresnahan
The effect of human cytomegalovirus (HCMV) gene expression on beta interferon (IFN-β) expression was examined. We demonstrate that the HCMV immediate-early 2 (IE2) gene product IE86 can effectively block the induction of IFN-β during HCMV infection. IE86 also efficiently blocked the induction of IFN-β following Sendai virus infection, demonstrating that IE86's ability to block induction of IFN-β is not limited to HCMV infection, identifying IE2 as an IFN-β antagonist.

15 January 2006 in Journal of Virology
Verified
Journal Article
Open access
PDF file
Travis TaylorTravis Taylor
Travis Taylor
WBWade A. Bresnahan
Wade A. Bresnahan
The effect of human cytomegalovirus (HCMV) gene expression on cytokine (beta interferon) and chemokine (RANTES, MIG, MCP-2, MIP-1α, and interleukin-8) expression was examined. We demonstrate that HCMV gene expression is required to suppress the transcriptional induction of these cytokines and that the HCMV immediate-early 2 gene product IE86 can effectively block the expression of cytokines and proinflammatory chemokines during HCMV and Sendai virus infection. Additionally, we present data on viral mutants and ectopic protein expression which demonstrate that pp65, another identified HCMV cytokine antagonist, is not involved in regulating these proinflammatory cytokines. This is the first report to demonstrate that IE86 can act to suppress virus-induced proinflammatory cytokine transcript expression, extending the antiviral properties of this multifunctional viral protein.

1 June 2019 in Cell Reports
Verified
Journal Article
Open access
ACAbhilash I. Chiramel
Abhilash I. Chiramel
NMNicholas R. Meyerson
Nicholas R. Meyerson
KMKristin L. McNally
Kristin L. McNally
RBRebecca M. Broeckel
Rebecca M. Broeckel
VMVanessa R. Montoya
Vanessa R. Montoya
Sonja BestSonja Best
Sonja Best
Tripartite motif-containing protein 5α (TRIM5α) is a cellular antiviral restriction factor that prevents early events in retrovirus replication. The activity of TRIM5α is thought to be limited to retroviruses as a result of highly specific interactions with capsid lattices. In contrast to this current understanding, we show that both human and rhesus macaque TRIM5α suppress replication of specific flaviviruses. Multiple viruses in the tick-borne encephalitis complex are sensitive to TRIM5α-dependent restriction, but mosquito-borne flaviviruses, including yellow fever, dengue, and Zika viruses, are resistant. TRIM5α suppresses replication by binding to the viral protease NS2B/3 to promote its K48-linked ubiquitination and proteasomal degradation. Importantly, TRIM5α contributes to the antiviral function of IFN-I against sensitive flaviviruses in human cells. Thus, TRIM5α possesses remarkable plasticity in the recognition of diverse virus families, with the potential to influence human susceptibility to emerging flaviviruses of global concern.

1 March 2005 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
YZYizhou Zou
Yizhou Zou
WBWade Bresnahan
Wade Bresnahan
Travis TaylorTravis Taylor
Travis Taylor
PSPeter Stastny
Peter Stastny
The MHC-encoded MHC class I-related chains A (MICA) glycoproteins are known to enhance the functions of NK and T cells by ligating the stimulating receptor NKG2D and appear to play an important role in host defense. Human CMV (HCMV) evades the immune response in many different ways, but has not previously been found to down-regulate MICA. We have found that a common form of MICA, which has a nucleotide insertion in exon 5 corresponding to the transmembrane region and no cytoplasmic tail, was increased on the surface of fibroblasts HFS-13 compared with the mock-infected sample of the same cells that had been cultured to confluence. However, an astrocytoma cell line, U373, which has a full-length variant of MICA, showed that the expression of MICA was decreased after HCMV infection. Retroviral transduction of different MICA alleles into fibroblasts HFF-D, which express no MICA of their own, established that full-length MICA was down-regulated by HCMV, and the truncated form was not. Fibroblasts with decreased MICA due to HCMV infection were found to be protected from NK cell killing, whereas in the presence of the truncated form of MICA, the virus-infected cells were destroyed. Thus, the truncated form of MICA, which is the most common, has a mutation that allows it to persist on the surface and hinder efforts of the virus to evade the immune response.